ENvue Medical, Inc.FEEDEarnings & Financial Report
ENvue Medical, Inc. is a medical technology firm specializing in advanced enteral feeding systems and related clinical support solutions. It serves healthcare providers, hospitals and long-term care facilities across North America, focusing on improving safety and efficiency of care for patients requiring enteral nutrition support.
FEED Q4 FY2025 Key Financial Metrics
Revenue
$312.0K
Gross Profit
$-370.0K
Operating Profit
$-14.8M
Net Profit
$-12.2M
Gross Margin
-118.6%
Operating Margin
-4748.1%
Net Margin
-3919.6%
YoY Growth
-29.7%
EPS
$-28.73
ENvue Medical, Inc. Q4 FY2025 Financial Summary
ENvue Medical, Inc. reported revenue of $312.0K (down 29.7% YoY) for Q4 FY2025, with a net profit of $-12.2M (down 754.6% YoY) (-3919.6% margin). Cost of goods sold was $682.0K, operating expenses totaled $14.4M.
Key Financial Metrics
| Total Revenue | $312.0K |
|---|---|
| Net Profit | $-12.2M |
| Gross Margin | -118.6% |
| Operating Margin | -4748.1% |
| Report Period | Q4 FY2025 |
ENvue Medical, Inc. Annual Revenue by Year
ENvue Medical, Inc. annual revenue history includes year-by-year totals (for example, 2025 revenue was $2.6M).
ENvue Medical, Inc. Quarterly Revenue & Net Profit History
ENvue Medical, Inc. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $312.0K | -29.7% | $-12.2M | -3919.6% |
| Q3 FY2025 | $722.0K | +92.0% | $510.0K | 70.6% |
| Q2 FY2025 | $494.0K | -39.5% | $-4.0M | -803.8% |
| Q1 FY2025 | $1.0M | +11.3% | $-2.5M | -243.4% |
| Q4 FY2024 | $444.0K | -62.3% | $-1.4M | -322.3% |
| Q3 FY2024 | $376.0K | -17.9% | $-998.0K | -265.4% |
| Q2 FY2024 | $817.0K | +177.9% | $-688.0K | -84.2% |
| Q1 FY2024 | $921.0K | +160.2% | $-588.0K | -63.8% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $921000 | $817000 | $376000 | $444000 | $1.0M | $494000 | $722000 | $312000 |
| YoY Growth | 160.2% | 177.9% | -17.9% | -62.3% | 11.3% | -39.5% | 92.0% | -29.7% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $6.2M | $5.7M | $4.7M | $3.6M | $44.1M | $51.5M | $54.4M | $41.1M |
| Liabilities | $2.7M | $2.9M | $2.8M | $3.0M | $8.4M | $11.0M | $11.9M | $7.6M |
| Equity | $3.5M | $2.8M | $1.9M | $627000 | $35.7M | $40.5M | $42.5M | $33.5M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $-579000 | $-553000 | $-836000 | $-548000 | $-1.3M | $-3.4M | $-2.0M | $-2.7M |